Carregant...
The direct-medical costs associated with interferon-based treatment for Hepatitis C in Vietnam
Background: Injectable interferon-based therapies have been used to treat hepatitis C virus (HCV) infection since 1991. International guidelines have now moved away from interferon-based therapy towards direct-acting antiviral (DAA) tablet regimens, because of their superior efficacy, excellent side...
Guardat en:
| Publicat a: | Wellcome Open Res |
|---|---|
| Autors principals: | , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
F1000 Research Limited
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7372532/ https://ncbi.nlm.nih.gov/pubmed/32734002 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/wellcomeopenres.15408.2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|